Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-VVA1, Intravaginal Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy
Investigational therapy for women who cannot, or should not, take supplemental estrogen Potential to be the first treatment for vulvar...